| |
|
|
|
TRACON Pharmaceuticals Inc.  
|
|
3.74 -0.02 (-0.01%) |
01-22 16:00 |
|
Open: |
3.8 |
Pre close: |
3.76 |
Target:
|
5.61
|
|
High: |
3.9 |
Low: |
3.66 |
Resistance:
|
4.80
5.61
|
|
Volume: |
286,252 |
Market Cap: |
15M |
Support:
|
3.11
2.07
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
3.74
 |
MACD |
MACD(12,26):
|
0.24 |
|
MA(20): |
2.81 |
Signal(12,26,9): |
0.06 |
|
MA(100): |
3.60  |
Stochastic Oscillator |
%K(14,3):
|
63.40 |
|
MA(250): |
6.41 |
%D(3): |
69.32 |
|
Average Volume(K) |
3-Month: |
44282
|
52-Week |
High:
|
17.30 |
|
10-Days: |
145005 |
Low: |
2.07 |
|
RSI |
RSI(14):
|
62.89 |
Change(%): |
-57.3 |
|
Financials, Statistics and Valuation |
|
EPS |
-8.857 |
Return on Equity (ttm) |
-162.6 |
Shares Out. (M) |
3.14 |
|
EPS Est. Current Year |
-1.570 |
Return on Assets (ttm) |
-47.0 |
Shares Float (M) |
1.90 |
|
EPS Est. Next Year |
-1.830 |
PEG Ratio |
0.00 |
% Held by Insiders |
3.69 |
|
EPS Est. Next Quarter |
-0.490 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
60.18 |
|
Forward EPS |
-1.527 |
Gross Profit (p.s.) |
-6.653 |
Shares Short (K) |
52 |
|
Book Value (p.s.) |
1.350 |
EBITDA (p.s.) |
-8.341 |
P/E |
-0.42 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
2.77 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-27.53 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-17.75 |
P/CF |
-0.43 |
|
|
|
|
|
|
